Ind-Swift launches Atorvastatin tablets in UK
Mumbai, May 16 : Indian pharmaceutical company Ind-Swift has launched generic formulations of the world's best selling drug Atorvastatin in UK in collaboration with Wockhardt UK Ltd. on the first day of its patent expiry.
Atorvastatin, is considered as the best selling drug with world market size of USUSD 16 billion.
The drug went off patent in Europe on May 6 and taking this opportunity Ind Swift Limited and its EU marketing partner Wockhardt UK Limited launched the generic version of the molecule in UK on day 1 after the patent expiry.
The product was launched in all its strengths i.e. 10mg, 20mg, 40mg and 80 mg.
Sirjiwan Singh, Managing Director Wockhardt UK Limited said, "Wockhardt UK is one of the major suppliers of healthcare products to the Retail Pharmacy and Hospitals in UK and the launch of generic version of Atorvastatin in collaboration with Ind Swift Limited is an important milestone for us."
N.R.Munjal, Vice Chairman of Ind-Swift Limited said, "With increase in demand for cost effective drugs for cardiovascular diseases, this generic launch is an excellent example of collaborative efforts of the two companies in leveraging on mutual strengths and competencies. We are targeting to capture a significant market share of this product in UK with in the first year of launch."
He said the company has few more such products in pipeline to be launched in European market in near future.